Drug
MIB-626
MIB-626 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_2
3
60%
Phase Distribution
2
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
3(60.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Completed2
Not yet recruiting2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (40.0%)
Phase 23 (60.0%)
Trials by Status
completed240%
active_not_recruiting120%
not_yet_recruiting240%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruitingphase_1
Sirtuin-NAD Activator in Alzheimer's Disease
NCT05040321
not_yet_recruitingphase_2
Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery
NCT07013591
not_yet_recruitingphase_1
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
NCT07278492
completedphase_2
Phase 2a MIB-626 vs. Placebo COVID-19
NCT05038488
completedphase_2
NAD+ Precursor Supplementation in Friedreich's Ataxia
NCT04817111
Clinical Trials (5)
Showing 5 of 5 trials
NCT05040321Phase 1
Sirtuin-NAD Activator in Alzheimer's Disease
NCT07013591Phase 2
Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery
NCT07278492Phase 1
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
NCT05038488Phase 2
Phase 2a MIB-626 vs. Placebo COVID-19
NCT04817111Phase 2
NAD+ Precursor Supplementation in Friedreich's Ataxia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5